Imran Avci (VU): Disposable, ultra-sensitive optical biosensors for early cancer diagnosis (COMB-O)
In the last decade, cancer has become a silent pandemic as it is the second leading cause of death globally. Early diagnosis is critical for successful treatment, and therefore we urgently need sensitive, specific and affordable solutions. The development of optical biosensors that can detect the cancer biomarkers in the bloodstream at a very early stage is such a solution. The innovation lies in a sensor platform that is based on a tiny, yet powerful photonic microchip and novel detection scheme (now in the stage of patent application). The aim is that the new biosensors will become a part of the routine tests of primary care providers and that they will save millions of lives eventually.
Zeliha Guler (Amsterdam UMC): Development of a novel wound-healing implant with localized estradiol delivery One out of four women is under risk for prolapse, and it increases up to 60% by age or giving birth. For the correction of prolapse permanent implants are being used, but they may cause clinical complications in the long term. […]
Ewelina Weglarz-Tomczak (UvA): Novel lysosomal protease inhibitors for the treatment of Alzheimer’s disease Highly specified proteases are the key regulators in the molecular mechanism of neurodegeneration in Alzheimer’s disease. AI-powered technology developed by NatInLab has led to the discovery of how those proteases are controlled in the human organism. Based on this knowledge, developing novel, […]
Marjon van Rijn (HvA): Journey to the end of life Research indicates that healthcare professionals often struggle to initiate conversations about the wishes and preferences for care and treatment at the end of life with older people. A partial solution lies in providing training for these discussions within a safe learning environment by way of […]